Who Paid My Doc
Guardian Connect
Device Continuous Glucose Monitoring
PDI 00763000002602
General payments
$29,896
Research payments
$2,613,589
Through program year 2025, $29,896 in general payments and $2,613,589 in research payments were reported against Guardian Connect (Continuous Glucose Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $255 | 6 |
| 2024 | General | $36 | 2 |
| 2024 | Research | $14,666 | 5 |
| 2023 | General | $1,725 | 66 |
| 2023 | Research | $211,288 | 75 |
| 2022 | General | $8,300 | 437 |
| 2022 | Research | $1,911,626 | 194 |
| 2021 | General | $19,580 | 530 |
| 2021 | Research | $476,010 | 77 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
1,041 general · 351 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.